Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 466-470

  Ausiello, Clara M ^a   Lande, Roberto ^a   Sala, Andrea La ^a   Urbani, Francesca ^a   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HEMAGGLUTININ; INTERLEUKIN 2; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ADULT; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0031872473     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515628     Document Type: Article

References (16)

1. Cherry JD. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr Infect Dis J 1997;16:S90-6
2. Hewlett EL. Pertussis: current concepts of pathogenesis and prevention. Pediatr Infect Dis J 1997;16:578-84.
3. Pichichero ME. Pertussis and the pertussis vaccines. Curr Opin Infect Dis 1993;6:558-64.
4. Redhead K, Watkins J, Barnard A, Mills KHG. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 1993;61:3190-8.
5. Cassone A, Ausiello CM, Urbani F, et al. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. Arch Pediatr Adolesc Med 1996;151:283-9.
6. Zepp F, Knuf M, Habermehl P, et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 1996;64:4078-84.
7. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KHG. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 1997;175:1246-50.
8. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction in children after primary vaccination with whole cell or acellular pertussis vaccines. Infect Immun 1997;65:2168-74.
9. Cattaneo L, Reed G, Haase DH, Wills MJ, Edwards MK. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996;173:1256-9.
10. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 1997;16:S85-9.
11. Ausiello CM, Urbani F, Gessani S, Spagnoli GC, Gomez MJ, Cassone A. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents of Candida albicans. Infect Immun 1993;61:4905-11.
12. Ausiello CM, la Sala A, Ramoni C, Urbani F, Funaro A, Malavasi F. Secretion of IFN-γ, IL-6, granulocyte-macrophage colony-stimulating factor, and IL-10 cytokines after activation of human purified T lymphocytes upon CD38 ligation. Cell Immunol 1996;173:192-7.
13. Shau H, Golub SH. Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells. J Immunol 1985;134:1136-41.
14. Mills KHG, Barnard A, Watkins J, Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993;61:399-410.
15. Di Tommaso A, Bartalini M, Peppoloni S, Podda A, Rappuoli R, De Magistris T. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. Vaccine 1997;15:1218-24.
16. Rota MC, Ausiello CM, D'Amelio R, et al. Prevalence of markers of exposure to Bordetella pertussis among Italian young adults. Clin Infect Dis 1998;26:297-302.